Neutrophils Oppose Uterine Epithelial Carcinogenesis via Debridement of Hypoxic Tumor Cells

Cancer Cell

Volumn 28, Issue 6, 2015, Pages 785-799

  Blaisdell, Adam ^a   Crequer, Amandine ^a   Columbus, Devin ^a   Daikoku, Takiko ^b,d   Mittal, Khush ^a   Dey, Sudhansu K ^b   Erlebacher, Adrian ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE RECEPTOR; AUTACOID; CHEMOKINE RECEPTOR CXCR2; COLONY STIMULATING FACTOR RECEPTOR; MYD88 PROTEIN, MOUSE; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; DEBRIDEMENT; EPITHELIUM; GENE; HISTOPATHOLOGY; HYPOXEMIA; INFLAMMATION; LYMPHOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH; UTERUS CANCER; ANIMAL; BIOLOGY; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CANCER STAGING; CARCINOMA, ENDOMETRIOID; CELL ADHESION; CELL HYPOXIA; CELL PROLIFERATION; CHEMOTAXIS; DEFICIENCY; ENZYMOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE TRANSFER; GENETIC DATABASE; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LEUKOCYTE ACTIVATION; METABOLISM; MORTALITY; NEUTROPHIL CHEMOTAXIS; OVARIAN NEOPLASMS; OVARIECTOMY; PATHOLOGY; PHAGOCYTOSIS; SURVIVAL ANALYSIS; TIME FACTOR; TUMOR CELL LINE; TUMOR MICROENVIRONMENT; TUMOR VOLUME; UTERUS;

ANIMALS; BONE MARROW TRANSPLANTATION; CARCINOMA, ENDOMETRIOID; CELL ADHESION; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOTAXIS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE TRANSFER TECHNIQUES; HUMANS; INFLAMMATION MEDIATORS; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; NEOPLASM STAGING; NEUTROPHIL ACTIVATION; NEUTROPHIL INFILTRATION; NEUTROPHILS; OVARIAN NEOPLASMS; OVARIECTOMY; PHAGOCYTOSIS; PTEN PHOSPHOHYDROLASE; RECEPTORS, COLONY-STIMULATING FACTOR; RECEPTORS, INTERLEUKIN-8B; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR BURDEN; TUMOR MICROENVIRONMENT; UTERUS;

EID: 84959216787     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2015.11.005     Document Type: Article

References (44)

1. Albanesi M., Mancardi D.A., Jönsson F., Iannascoli B., Fiette L., Di Santo J.P., Lowell C.A., Bruhns P. Neutrophils mediate antibody-induced antitumor effects in mice. Blood 2013, 122:3160-3164.
2. Bald T., Quast T., Landsberg J., Rogava M., Glodde N., Lopez-Ramos D., Kohlmeyer J., Riesenberg S., van den Boorn-Konijnenberg D., Hömig-Hölzel C., et al. Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma. Nature 2014, 507:109-113.
3. Beauparlant S.L., Read P.W., Di Cristofano A. In vivo adenovirus-mediated gene transduction into mouse endometrial glands: a novel tool to model endometrial cancer in the mouse. Gynecol. Oncol. 2004, 94:713-718.
4. Bongers G., Pacer M.E., Geraldino T.H., Chen L., He Z., Hashimoto D., Furtado G.C., Ochando J., Kelley K.A., Clemente J.C., et al. Interplay of host microbiota, genetic perturbations, and inflammation promotes local development of intestinal neoplasms in mice. J. Exp. Med. 2014, 211:457-472.
5. Brandau S., Dumitru C.A., Lang S. Protumor and antitumor functions of neutrophil granulocytes. Semin. Immunopathol. 2013, 35:163-176.
6. Campbell E.L., Bruyninckx W.J., Kelly C.J., Glover L.E., McNamee E.N., Bowers B.E., Bayless A.J., Scully M., Saeedi B.J., Golden-Mason L., et al. Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. Immunity 2014, 40:66-77.
7. Chen Z., Trotman L.C., Shaffer D., Lin H.K., Dotan Z.A., Niki M., Koutcher J.A., Scher H.I., Ludwig T., Gerald W., et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005, 436:725-730.
8. Colgan S.P., Dzus A.L., Parkos C.A. Epithelial exposure to hypoxia modulates neutrophil transepithelial migration. J. Exp. Med. 1996, 184:1003-1015.
9. Coppé J.P., Desprez P.Y., Krtolica A., Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 2010, 5:99-118.
10. Daikoku T., Hirota Y., Tranguch S., Joshi A.R., DeMayo F.J., Lydon J.P., Ellenson L.H., Dey S.K. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res. 2008, 68:5619-5627.
11. Daikoku T., Terakawa J., Hossain M.M., Yoshie M., Cappelletti M., Yang P., Ellenson L.H., Dey S.K. Mammalian target of rapamycin complex 1 and cyclooxygenase 2 pathways cooperatively exacerbate endometrial cancer. Am. J. Pathol. 2014, 184:2390-2402.
12. Di Cristofano A., Ellenson L.H. Endometrial carcinoma. Annu. Rev. Pathol. 2007, 2:57-85.
13. Donskov F. Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin. Cancer Biol. 2013, 23:200-207.
14. Dwyer M.P., Yu Y. CXCR2 receptor antagonists: a medicinal chemistry perspective. Curr. Top. Med. Chem. 2014, 14:1590-1605.
15. Eltzschig H.K., Bratton D.L., Colgan S.P. Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases. Nat. Rev. Drug Discov. 2014, 13:852-869.
16. Eruslanov E.B., Bhojnagarwala P.S., Quatromoni J.G., Stephen T.L., Ranganathan A., Deshpande C., Akimova T., Vachani A., Litzky L., Hancock W.W., et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J. Clin. Invest. 2014, 124:5466-5480.
17. Fridlender Z.G., Sun J., Kim S., Kapoor V., Cheng G., Ling L., Worthen G.S., Albelda S.M. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009, 16:183-194.
18. Granot Z., Henke E., Comen E.A., King T.A., Norton L., Benezra R. Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell 2011, 20:300-314.
19. Grivennikov S.I., Wang K., Mucida D., Stewart C.A., Schnabl B., Jauch D., Taniguchi K., Yu G.Y., Osterreicher C.H., Hung K.E., et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012, 491:254-258.
20. Heng T.S., Painter M.W. The Immunological Genome Project: networks of gene expression in immune cells. Nat. Immunol. 2008, 9:1091-1094. Immunological Genome Project Consortium.
21. Houghton A.M., Rzymkiewicz D.M., Ji H., Gregory A.D., Egea E.E., Metz H.E., Stolz D.B., Land S.R., Marconcini L.A., Kliment C.R., et al. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat. Med. 2010, 16:219-223.
22. Howlader, N., Noone, A.M., Krapcho, M., Garshell, J., Miller, D., Altekruse, S.F., Kosary, C.L., Yu, M., Ruhl, J., Tatalovich, Z., et al. (2014). SEER cancer statistics review, 1975-2011, National Cancer Institute. Bethesda, MD, based on November 2013 SEER data submission, posted to the SEER web site, April 2014. http://seer.cancer.gov/csr/1975_2011/.
23. Jamieson T., Clarke M., Steele C.W., Samuel M.S., Neumann J., Jung A., Huels D., Olson M.F., Das S., Nibbs R.J., Sansom O.J. Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J. Clin. Invest. 2012, 122:3127-3144.
24. Johnston R.A., Mizgerd J.P., Shore S.A. CXCR2 is essential for maximal neutrophil recruitment and methacholine responsiveness after ozone exposure. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288:L61-L67.
25. Kang T.W., Yevsa T., Woller N., Hoenicke L., Wuestefeld T., Dauch D., Hohmeyer A., Gereke M., Rudalska R., Potapova A., et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 2011, 479:547-551.
26. Katoh H., Wang D., Daikoku T., Sun H., Dey S.K., Dubois R.N. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell 2013, 24:631-644.
27. Kousis P.C., Henderson B.W., Maier P.G., Gollnick S.O. Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils. Cancer Res. 2007, 67:10501-10510.
28. Liu F., Wu H.Y., Wesselschmidt R., Kornaga T., Link D.C. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 1996, 5:491-501.
29. Liu Z., Shapiro S.D., Zhou X., Twining S.S., Senior R.M., Giudice G.J., Fairley J.A., Diaz L.A. A critical role for neutrophil elastase in experimental bullous pemphigoid. J. Clin. Invest. 2000, 105:113-123.
30. Mantovani A., Cassatella M.A., Costantini C., Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 2011, 11:519-531.
31. Mishalian I., Bayuh R., Levy L., Zolotarov L., Michaeli J., Fridlender Z.G. Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression. Cancer Immunol. Immunother. 2013, 62:1745-1756.
32. Molloy M.J., Grainger J.R., Bouladoux N., Hand T.W., Koo L.Y., Naik S., Quinones M., Dzutsev A.K., Gao J.L., Trinchieri G., et al. Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. Cell Host Microbe 2013, 14:318-328.
33. Newman A.M., Liu C.L., Green M.R., Gentles A.J., Feng W., Xu Y., Hoang C.D., Diehn M., Alizadeh A.A. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 2015, 12:453-457.
34. Owen C.A., Campbell E.J. The cell biology of leukocyte-mediated proteolysis. J. Leukoc. Biol. 1999, 65:137-150.
35. Prince L.R., Whyte M.K., Sabroe I., Parker L.C. The role of TLRs in neutrophil activation. Curr. Opin. Pharmacol. 2011, 11:397-403.
36. Riedle B., Kerjaschki D. Reactive oxygen species cause direct damage of Engelbreth-Holm-Swarm matrix. Am. J. Pathol. 1997, 151:215-231.
37. Souto J.C., Vila L., Brú A. Polymorphonuclear neutrophils and cancer: intense and sustained neutrophilia as a treatment against solid tumors. Med. Res. Rev. 2011, 31:311-363.
38. Tagliani E., Shi C., Nancy P., Tay C.S., Pamer E.G., Erlebacher A. Coordinate regulation of tissue macrophage and dendritic cell population dynamics by CSF-1. J. Exp. Med. 2011, 208:1901-1916.
39. Toso A., Revandkar A., Di Mitri D., Guccini I., Proietti M., Sarti M., Pinton S., Zhang J., Kalathur M., Civenni G., et al. Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity. Cell Rep. 2014, 9:75-89.
40. Trinchieri G. Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu. Rev. Immunol. 2012, 30:677-706.
41. Venaille T.J., Mendis A.H., Phillips M.J., Thompson P.J., Robinson B.W. Role of neutrophils in mediating human epithelial cell detachment from native basement membrane. J. Allergy Clin. Immunol. 1995, 95:597-606.
42. Wallace A.E., Gibson D.A., Saunders P.T., Jabbour H.N. Inflammatory events in endometrial adenocarcinoma. J. Endocrinol. 2010, 206:141-157.
43. Weigelt B., Warne P.H., Lambros M.B., Reis-Filho J.S., Downward J. PI3K pathway dependencies in endometrioid endometrial cancer cell lines. Clin. Cancer Res. 2013, 19:3533-3544.
44. Zhang H., Labouesse M. The making of hemidesmosome structures in vivo. Dev. Dyn. 2010, 239:1465-1476.